Azumino, Japan

Yousuke Mutai

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yousuke Mutai. Retrieved from https://idiyas.com/inventor/yousuke-mutai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yousuke Mutai: Innovator in Pharmaceutical Chemistry

Introduction

Yousuke Mutai is a notable inventor based in Azumino, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazole derivatives.

Latest Patents

Yousuke Mutai holds a patent for a novel pyrazole derivative or a pharmaceutically acceptable salt thereof. This invention provides a pharmaceutical composition that includes the compound, which exhibits TRPM8 inhibitory effects. The compound is represented by a specific formula and is useful in treating or preventing diseases caused by hyperexcitability or disorders of afferent neurons.

Career Highlights

Mutai is associated with Kissei Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating compounds that can address various medical conditions effectively.

Collaborations

Yousuke Mutai has collaborated with notable colleagues, including Hideaki Hirasawa and Fumiya Tanada. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Yousuke Mutai's innovative work in developing pharmaceutical compounds highlights his significant role in the field of medicine. His contributions continue to pave the way for advancements in treating neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…